Severity: Warning
Message: file_get_contents(https://...@remsenmedia.com&api_key=81853a771c3a3a2c6b2553a65bc33b056f08&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Giant cell tumors are uncommonly found within the craniofacial skeleton, and of those within the head and neck, are exceedingly rare in the maxilla. Here the authors present 2 cases of large, maxillary giant cell tumors: one presenting with mass-effect symptoms and another presenting from incidental findings on routine orthodontic care. Both patients were treated surgically with transoral and endoscopic transnasal excision and demonstrated favorable surgical results. One patient demonstrated no recurrence after 9 years and the other patient was disease free after 4 years. The authors end by discussing the role of emerging biologic agents, such as denosumab, for treating giant cell tumors of the jaws.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SCS.0000000000008689 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!